You have 9 free searches left this month | for more free features.

Parapsoriasis

Showing 1 - 22 of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Mycosis Fungoides of Skin Trial in Istanbul (videodermoscopy, lesional capillaroscopy)

Completed
  • Mycosis Fungoides of Skin
  • videodermoscopy, lesional capillaroscopy
  • Istanbul, Istanbul/Fatih, Turkey
    Istanbul Teaching and Research Hospital
Jun 28, 2022

Parapsoriasis Trial in United States (Apremilast, Placebo, Placebo-Apremilast)

Completed
  • Parapsoriasis
  • Birmingham, Alabama
  • +25 more
Mar 3, 2022

Parapsoriasis, Healthy Volunteers Trial in Austin (CC-90005, Placebo)

Terminated
  • Parapsoriasis
  • Healthy Volunteers
  • Austin, Texas
    PPD Development, LP
Nov 14, 2019

Parapsoriasis Trial in Reamat- Gan (natural gels, Placebo)

Completed
  • Parapsoriasis
  • natural gels
  • Placebo
  • Reamat- Gan, Ramat-almogi, Israel
    Chaim Sheba Med. center. Dept. Of Dermatology
Jul 19, 2018

Hypercholesterolemia Trial in Worldwide (ALIROCUMAB SAR236553 (REGN727), (for injection training only), ezetimibe)

Completed
  • Hypercholesterolemia
  • ALIROCUMAB SAR236553 (REGN727)
  • +5 more
  • Graz, Austria
  • +152 more
Mar 21, 2022

Pityriasis Lichenoides : Anatomo-clinical Aspects and Follow-up

Unknown status
  • Pityriasis Lichenoides
    • (no location specified)
    Apr 15, 2019

    Chronic Kidney Disease Trial in Worldwide (Finerenone (BAY94-8862), Placebo)

    Completed
    • Chronic Kidney Disease
    • Finerenone (BAY94-8862)
    • Placebo
    • Birmingham, Alabama
    • +977 more
    Jun 29, 2021

    Psoriatic Arthritis Trial in Worldwide (Etanercept, Methotrexate, Placebo to Etanercept)

    Completed
    • Psoriatic Arthritis
    • Tuscaloosa, Alabama
    • +137 more
    Feb 2, 2021

    Coronary Artery Disease, Myocardial Ischemia Trial in Japan (XIENCE PRIME®/XIENCE Xpedition™, Absorb™ BVS)

    Completed
    • Coronary Artery Disease
    • Myocardial Ischemia
    • XIENCE PRIME®/XIENCE Xpedition™
    • Absorb™ BVS
    • Nagoya-shi, Aichi, Japan
    • +38 more
    Oct 5, 2020

    Coronary Artery Disease Trial in Ferrara, London (Ivabradine, Placebo)

    Completed
    • Coronary Artery Disease
    • Ferrara, Italy
    • +1 more
    Mar 2, 2020

    Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Alabaster, Alabama
    • +427 more
    Jul 3, 2019

    Moderate Risk of CVD Trial in Worldwide (Aspirin (Acetylsalicylic acid, BAYE4465), Placebo)

    Completed
    • Moderate Risk of CVD
    • Aspirin (Acetylsalicylic acid, BAYE4465)
    • Placebo
    • Birmingham, Alabama
    • +465 more
    Sep 26, 2018

    Type 2 Diabetes Trial in Worldwide (Exenatide Once Weekly, Placebo)

    Completed
    • Type 2 Diabetes Mellitus
    • Exenatide Once Weekly
    • Placebo
    • Birmingham, Alabama
    • +629 more
    Jul 13, 2018

    COPD (COPD) Trial in Worldwide (QVA149, Long acting B2 agonist (LABA) and inhaled corticosteroid (ICS))

    Completed
    • Chronic Obstructive Pulmonary Disease (COPD)
    • QVA149
    • Long acting B2 agonist (LABA) and inhaled corticosteroid (ICS)
    • Caba, Buenos Aires, Argentina
    • +495 more
    May 5, 2016

    Hepatitis C, Chronic Trial in Worldwide (BI 201335 NA 240 mg QD / LI, PegIFN/RBV, BI 201335 NA 120mg QD / LI)

    Completed
    • Hepatitis C, Chronic
    • BI 201335 NA 240 mg QD / LI
    • +5 more
    • San Francisco, California
    • +99 more
    Oct 14, 2015

    Parapsoriasis Trial in Philadelphia (Bexarotene 1% gel)

    Terminated
    • Parapsoriasis
    • Bexarotene 1% gel
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Apr 15, 2013

    CHF Trial in Worldwide (Irbesartan, Placebo)

    Completed
    • Congestive Heart Failure
    • Birmingham, Alabama
    • +230 more
    Mar 18, 2015

    Pulmonary Disease, Chronic Obstructive Trial in Worldwide (tiotropium, )

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Anniston, Alabama
    • +489 more
    May 15, 2014

    Psoriasis, Parapsoriasis Trial (Infliximab)

    Completed
    • Psoriasis
    • Parapsoriasis
    • (no location specified)
    May 16, 2011

    Postmenopausal Osteoporosis Trial in Worldwide (risedronate)

    Completed
    • Postmenopausal Osteoporosis
    • Birmingham, Alabama
    • +44 more
    Apr 15, 2013

    Multiple Sclerosis Trial in Worldwide (Fingolimod 0.5 mg, Fingolimod 1.25 mg)

    Completed
    • Multiple Sclerosis
    • Fingolimod 0.5 mg
    • Fingolimod 1.25 mg
    • Chatswood, Australia
    • +104 more
    Jun 9, 2012